$CTIX Recent Headlines Cellceutix jumps on QIDP tag

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$CTIX Recent Headlines

Cellceutix jumps on QIDP tag 1:23 p.m. Dec. 8, 2014 - Seeking Alpha
Cellceutix Brilacidin IND effective, Phase 2 to begin 9:31 a.m. Oct. 13, 2014 - Seeking Alpha
Regulatory Support Creates Opportunity For Antibiotic Makers Otonomy And Cellceutix 9:02 a.m. Sept. 25, 2014 - Seeking Alpha
Update: Cellceutix Calls Out To President Obama About Brilacidin 2:38 p.m. Sept. 21, 2014 - Seeking Alpha
10-K: CELLCEUTIX CORP 12:53 p.m. Sept. 15, 2014 - Edgar Online - (EDG = 10Q, 10K)
Update: Cellceutix's Antibiotic Brilacidin Should Move Share Price Before Kevetrin Or Prurisol 2:06 a.m. Sept. 14, 2014 - Seeking Alpha
The Antibiotic Resistance Triple Threat 1:05 p.m. Sept. 4, 2014 - Seeking Alpha
Cellceutix completes enrollment in Brilacidin trial 8:45 a.m. Aug. 19, 2014 - Seeking Alpha
Did The Medicines Company Trump Cellceutix And Others In A $1B-Plus Skin Infection Market? 10:38 a.m. Aug. 14, 2014 - Seeking Alpha
10-Q: CELLCEUTIX CORP 9:15 a.m. May 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
Huge Opportunities Are Now Possible Due To Market Inefficiencies In Valuing Antibiotic Companies Such As Cubist, Durata, And Cellceutix 9:34 a.m. April 25, 2014 - Seeking Alpha
10-Q: CELLCEUTIX CORP 4:09 p.m. Feb. 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
Cellceutix Is Significantly Undervalued Considering The Value Of Brilacidin 9:31 a.m. Jan. 28, 2014 - Seeking Alpha
Cellceutix Corp.: A Biotech With High Risk But High Reward 3:17 p.m. Jan. 2, 2014 - Wall St. Cheat Sheet
Cellceutix: An Undiscovered Company Set To Rise In 2014 9:06 a.m. Dec. 16, 2013 - Seeking Alpha
3 Innovative Biotech Companies Poised To Shine At TAP Partnership Conference 5:38 a.m. Nov. 19, 2013 - Seeking Alpha
10-Q: CELLCEUTIX CORP 5:06 p.m. Nov. 8, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-K: CELLCEUTIX CORP 3:01 p.m. Sept. 30, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q: CELLCEUTIX CORP 1:18 p.m. May 20, 2013 - Edgar Online - (EDG = 10Q, 10K)
Interview with CEO of Cellceutix Corporation: Leo Ehrlich 8:57 a.m. Nov. 15, 2011 - GuruFocus.com


Cellceutix: Prurisol(TM) for Psoriasis -- FDA Agrees That Phase 2 Study May Begin 7:41 a.m. Dec. 10, 2014 - Marketwired
Cellceutix Antibiotic Brilacidin Receives QIDP Designation From FDA 7:01 a.m. Dec. 8, 2014 - Marketwired
Cellceutix: December to Be Momentous Month in Company's History 7:02 a.m. Nov. 24, 2014 - Marketwired
These Medical Stocks Are Reaching A Fever Pitch Following Midterm Elections 9:54 a.m. Nov. 12, 2014 - ACCESSWIRE
Patient Enrollment in Cellceutix Phase 2 Clinical Trial of Brilacidin-OM for Oral Mucositis Targeted to Begin in December 2014 7:01 a.m. Nov. 11, 2014 - Marketwired
Cellceutix's New Chief Operating Officer Dr. James Alexander Addresses Shareholders 6:00 a.m. Oct. 31, 2014 - Marketwired
Cellceutix Announces Positive Top-Line Data From Phase 2b ABSSSI Trial; Single-Dose Brilacidin Comparable to 7-Days of Daptomycin 10:52 a.m. Oct. 23, 2014 - Marketwired
Cellceutix Investigational New Drug (IND) Application Becomes Effective, Selects First Site for Phase 2 Clinical Trial of New Treatment for Oral Mucositis 8:02 a.m. Oct. 13, 2014 - Marketwired
Cellceutix Provides Update to Shareholders 11:30 a.m. Sept. 24, 2014 - Marketwire
Cellceutix to President Obama: We Have the Tools and Will Rise Up to the Challenge to Prevent Antibiotic Resistant Bacteria Becoming a Serious Threat to Public Health 6:15 a.m. Sept. 19, 2014 - Marketwire
Cellceutix Provides Initial Observations of Completed ABSSSI Phase 2b Trial; Company Submits Investigational New Drug Application to FDA for Phase 2 Trial of Brilacidin-OM for Oral Mucositis 2:01 p.m. Sept. 9, 2014 - Marketwire
Cellceutix to Present at Rodman & Renshaw's 16th Annual Global Investment Conference 10:17 a.m. Sept. 5, 2014 - Marketwire
Cellceutix Appoints Dr. Barry Schechter to Board of Directors as Company Focuses on Meeting Requirements for Stock Exchange Uplisting 6:01 a.m. Sept. 2, 2014 - Marketwire
Cellceutix Completes Enrollment in Phase 2b Clinical Trial of Brilacidin for Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 7:31 a.m. Aug. 19, 2014 - Marketwire
Cellceutix Prepares for Phase 2 Clinical Trial of Brilacidin-OM for Oral Mucositis 6:01 a.m. Aug. 11, 2014 - Marketwire
Cellceutix Anti-Psoriasis Drug Prurisol Meets Primary Endpoint of Clinical Trial 5:04 a.m. Aug. 8, 2014 - Marketwire
Cellceutix Believes Brilacidin on Track to Help U.S. Avoid Falling Into Post-Antibiotic Era; Completion of Enrollment in Phase 2b Trial for Acute Bacterial Skin and Skin Structure Infections Expected This Month 6:01 a.m. Aug. 4, 2014 - Marketwire
Cellceutix Announces Breakthrough in the Formulation of Its Novel Antibiotic Brilacidin(TM), Plans Studies to Treat Diabetic Foot Ulcers 6:01 a.m. July 14, 2014 - Marketwire
Cellceutix Brilacidin ABSSSI Trial Gets Positive Review by Data Safety Monitoring Board; Best Possible Outcome, No Treatment-Related Serious Adverse Events (SAEs) 6:00 a.m. July 7, 2014 - Marketwire
Cellceutix Anti-Fungal Compounds Awarded $1.5 Million SBIR Grant 6:01 a.m. June 23, 2014 - Marketwire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NJ Weather Station Launch: Impact on Community & Climate

Updated Category News Views 40

Franklin Township Debuts Its Latest Weather Ally Imagine getting timely, precise weather updates at your fingertips in Franklin Township. Thanks to the coordinated efforts of New Jersey American Water and Rutgers University, that's now a reality. This isn't just another weather app update; we're talking about a tangible, real-world data station serving the Rutgers New...

Continue Reading
Marc Jacobs Expansion: Bold Moves, Bigger Markets

Updated Category News Views 64

Marc Jacobs' Bold Move into Greater China There's a new gust blowing through the retail fashion industry, and it's coming from the partnership between WHP Global, G-III Apparel Group, and I.T Group. These seasoned players are betting big on Marc Jacobs to expand its footprint in the Greater China region. I can practically see the dollar signs in their eyes as they dive...

Continue Reading
Blue Moon Metals Gears Up for Springer Mine Revamp

Updated Category News Views 30

Getting Set for a Big Move Blue Moon Metals Inc. isn't sitting around with its thumbs in its pockets. The company has made some strides with their Springer Tungsten Mine project in Imlay, Nevada. Let's break down what these folks are up to. Refurbished Up for the Fast Track The rock mover here is the refurbishment of the Springer processing plant. You don't just snap your...

Continue Reading
Netcapital's 28.62% Plunge: A Fraudulent Drama Unfolds

Updated Category News Views 125

Netcapital: The Plunge Heard 'Round the Market There it is, clear as day—Netcapital’s (NASDAQ: NCPL) stock plummeting 28.62% like a lead balloon. Shareholders had to watch in horror as pieces of their investments seemed to evaporate, all thanks to a swirl of alleged fraud. You can't just shrug off accusations that a company you've betted on has been cooking its books,...

Continue Reading
Moody's Boosts Danaos Outlook, Debt Rating Upgrade

Updated Category News Views 24

A Shot of Confidence for Danaos Here's one to mull over—Moody's just gave Danaos Corporation a well-deserved pat on the back. With a nudge in the right direction, they've switched up the outlook on Danaos' Ba1 Corporate Family Rating from stable to positive. Not only that, but they've given a thumbs up to their senior unsecured notes, bumping them from Ba2 to Ba1. Why...

Continue Reading
AI Deepfakes Met Their Match: IC-Corp's New Patent

Updated Category News Views 86

The Deepfake Fraud Reality Slap You know, in a world where you can't trust your own eyes on a video call, trust gets a bit sketchy, right? Imagine this scenario—an unsuspecting finance employee, surrounded by familiar faces and voices, only to wind up sending $25.6 million to fraudsters who weren't even real. A chilling real-world example from January 2024, courtesy of...

Continue Reading
Gentex Faces Investigation as Shares Tumble 7%

Updated Category News Views 76

Investigating Gentex's Financial Setback Gentex Corporation, ticker NASDAQ:GNTX, is caught in a bit of a blizzard right now. Their shares took a nosedive, down 7%, after some messy numbers came out in their third-quarter report—tariffs and the kind of pricing pressure that makes grown investors wince. If you threw your chips in on Gentex and got burned, the lawyers are...

Continue Reading
Cognizant & EBRD Unite for Tech Transformation Push

Updated Category News Views 164

An Unexpected Collaboration to Watch Sometimes partnerships come out of left field, like this one between Cognizant and the European Bank for Reconstruction and Development (EBRD). These two are teaming up to inject some serious tech smarts into the Bank's operations over the next five years. What's interesting here is the role AI and automation play in their grand...

Continue Reading
Sanctuary Medicinals Opens New Saugus Dispensary with a Bang

Updated Category News Views 101

Saugus Gets a New Neighbor: Sanctuary Medicinals October 30th is shaping up to be quite the spectacle in Saugus, Massachusetts, with Sanctuary Medicinals pulling out all the stops for their Halloween-themed Grand Opening. This is more than just a new dispensary popping up—it's a little celebration of the community they've become a part of. So, if you thought cannabis...

Continue Reading
MacDonald Steps Up as President at California Bank

Updated Category News Views 57

New Leadership at California Bank & Trust It's a big shakeup in the banking lanes today as Michael MacDonald grabs the helm at California Bank & Trust (CB&T). He's stepping into the President's shoes, bringing along a toolkit of experience and know-how that's tough to find elsewhere. Under his watch, CB&T aims to blend the nimble maneuvering of local banks with the clout...

Continue Reading

Top 5 Most Recently Viewed Articles

RF Industries Shows Strong Performance in Latest Earnings Call

Updated Category News Views 102

RF Industries Reports Strong Growth in Q3 FY 2024 RF Industries (NASDAQ: RFIL), a leader in designing and manufacturing interconnect products along with complex cable assemblies, has revealed impressive outcomes during its recent earnings call. The company experienced a significant year-on-year growth of 7.6% in net sales, totaling $16.8 million. Furthermore, RF...

Continue Reading
Understanding the Upcoming Class Action for Metagenomi, Inc.

Updated Category News Views 126

Upcoming Class Action Lawsuit Against Metagenomi, Inc. Investors are being advised about the significant upcoming deadline in the class action lawsuit involving Metagenomi, Inc. This lawsuit is particularly relevant for those who acquired securities of Metagenomi, Inc. (MGX) during its initial public offering (IPO) held in February 2024. The deadline to file a lead...

Continue Reading
Arthur Hayes Discusses the New Era of Stablecoin Strategy

Updated Category News Views 157

Arthur Hayes on the Future of Stablecoins Arthur Hayes has recently shared compelling insights about the evolving landscape of stablecoins and their implications for the financial markets. He emphasizes that the U.S. government's regulatory decisions regarding stablecoins will significantly influence how these digital assets are utilized as a financial tool. The Role of...

Continue Reading
Baird Initiates Concentrix Coverage with Promising Growth Outlook

Updated Category News Views 47

Baird Initiates Coverage of Concentrix with Outperform Rating Baird has recently begun coverage on Concentrix Corporation (NASDAQ:CNXC), a prominent player in the customer care and IT consulting services arena. The firm has assigned an Outperform rating to the stock, setting a price target of $70.00. This decision reflects Baird's confidence in Concentrix's robust...

Continue Reading
Understanding Micro and Macro Perspectives on Affordability

Updated Category News Views 73

Micro Versus Macro Thinking: A Deep Dive From the moment we enter this world, our existence is shaped by micro-level realities. Every action we take in our daily lives, aimed at survival or personal fulfillment, is influenced by a basic understanding of these immediate truths. Micro thinking asks the fundamental question: "How do I succeed in this immediate environment?"...

Continue Reading